Your browser doesn't support javascript.
loading
Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
Weigel, G; Griesmacher, A; Zuckermann, A O; Laufer, G; Mueller, M M.
Afiliação
  • Weigel G; Department of Cardiothoracic Surgery, University of Vienna Medical School, and Ludwig Boltzmann Institute, Vienna, Austria.
Clin Pharmacol Ther ; 69(3): 137-44, 2001 Mar.
Article em En | MEDLINE | ID: mdl-11240978
ABSTRACT

BACKGROUND:

Mycophenolic acid is reported to provide effective immunosuppression by inhibiting inosine monophosphate dehydrogenase. In an attempt to monitor the biological effects of long-term therapy with mycophenolate mofetil, we measured levels of guanosine 5' triphosphate and adenosine 5' triphosphate in red blood cells (RBCs) of patients after heart transplantations.

METHODS:

Fifty-two patients enrolled in the study were randomly assigned to one of two groups. Patients in the control group (n = 27) received cyclosporine A (INN, ciclosporin), azathioprine, and prednisone. Patients in the study group (n = 25) were switched from azathioprine to mycophenolate mofetil 3 months after the heart transplantation. Adenosine 5' triphosphate and guanosine 5' triphosphate levels were determined by means of HPLC. The activities of inosine monophosphate dehydrogenase and hypoxanthine-guanine phosphoribosyltransferase, which are responsible for guanine nucleotide formation, were measured in RBCs by radiochemical methods.

RESULTS:

Adenosine 5' triphosphate levels were unchanged in patients treated with mycophenolate mofetil, whereas those of the control group who received azathioprine (from 142 +/- 26 pmol/10(6) RBCs to 165 +/- 25 pmol/10(6) RBCs; P <.001) increased. As the length of mycophenolate mofetil therapy increased, patients in the study group showed significantly elevated guanosine 5' triphosphate levels (15.6 +/- 6.1 pmol/10(6) RBCs versus 6.6 +/- 2.1 pmol/10(6) RBCs; P <.001) and a 5-fold increase in inosine monophosphate dehydrogenase activity (108.6 +/- 13.3 pmol/mg of protein per hour versus 22.5 +/- 1.7 pmol/mg of protein per hour; P <.001) compared with the control group. In addition, a slight but significant enhancement of hypoxanthine-guanine phosphoribosyltransferase activity was seen in the mycophenolate mofetil group.

CONCLUSIONS:

Our studies have shown that long-term administration of mycophenolate mofetil is associated with increasing guanosine 5' triphosphate levels in RBCs as the result of an induction of inosine monophosphate dehydrogenase and hypoxanthine-guanine phosphoribosyltransferase activities in erythrocytes.
Assuntos
Buscar no Google
Bases de dados: MEDLINE Assunto principal: Azatioprina / Indução Enzimática / Transplante de Coração / Inibidores Enzimáticos / Guanosina Trifosfato / Imunossupressores / IMP Desidrogenase / Ácido Micofenólico Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2001 Tipo de documento: Article País de afiliação: Áustria
Buscar no Google
Bases de dados: MEDLINE Assunto principal: Azatioprina / Indução Enzimática / Transplante de Coração / Inibidores Enzimáticos / Guanosina Trifosfato / Imunossupressores / IMP Desidrogenase / Ácido Micofenólico Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2001 Tipo de documento: Article País de afiliação: Áustria